97 related articles for article (PubMed ID: 29777878)
1. Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis.
Ding L; Zhu C; Yu F; Wu P; Chen G; Ullah A; Wang K; Sun M; Li J; Oupický D
Nanomedicine; 2018 Aug; 14(6):1765-1776. PubMed ID: 29777878
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.
Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D
J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934
[TBL] [Abstract][Full Text] [Related]
3. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats.
Zhang YP; Li WB; Wang WL; Liu J; Song SX; Bai LL; Hu YY; Yuan YD; Zhang M
Acta Pharmacol Sin; 2012 Jul; 33(7):897-908. PubMed ID: 22659625
[TBL] [Abstract][Full Text] [Related]
4. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl
Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D
Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436
[TBL] [Abstract][Full Text] [Related]
5. ERK5 regulates basic fibroblast growth factor-induced type 1 plasminogen activator inhibitor expression and cell proliferation in lung fibroblasts.
Han JH; Hwang AR; Nam DH; Kim S; Choi HC; Lim JH; Woo CH
Life Sci; 2015 Aug; 135():1-8. PubMed ID: 26032256
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling.
Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX
Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499
[TBL] [Abstract][Full Text] [Related]
7. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
8. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T
Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864
[TBL] [Abstract][Full Text] [Related]
9. Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer.
Zhou Y; Yu F; Zhang F; Chen G; Wang K; Sun M; Li J; Oupický D
Biomacromolecules; 2018 Feb; 19(2):392-401. PubMed ID: 29350899
[TBL] [Abstract][Full Text] [Related]
10. Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice.
Moshai EF; Wémeau-Stervinou L; Cigna N; Brayer S; Sommé JM; Crestani B; Mailleux AA
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):11-25. PubMed ID: 24450438
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.
Makino H; Aono Y; Azuma M; Kishi M; Yokota Y; Kinoshita K; Takezaki A; Kishi J; Kawano H; Ogawa H; Uehara H; Izumi K; Sone S; Nishioka Y
J Med Invest; 2013; 60(1-2):127-37. PubMed ID: 23614921
[TBL] [Abstract][Full Text] [Related]
12. Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis.
Liu R; Chen H; Bai H; Zhang W; Wang X; Qin X; Zhang X; Li W; Liang X; Hai C
Toxicol Lett; 2013 Jun; 220(1):15-25. PubMed ID: 23570914
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture.
Chen X; Sun R; Hu J; Mo Z; Yang Z; Liao D; Zhong N
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):278-86. PubMed ID: 18684219
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists.
Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D
Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651
[TBL] [Abstract][Full Text] [Related]
15. Bach1 siRNA attenuates bleomycin-induced pulmonary fibrosis by modulating oxidative stress in mice.
Liu Y; Zheng Y
Int J Mol Med; 2017 Jan; 39(1):91-100. PubMed ID: 27959382
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
Tager AM; Kradin RL; LaCamera P; Bercury SD; Campanella GS; Leary CP; Polosukhin V; Zhao LH; Sakamoto H; Blackwell TS; Luster AD
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):395-404. PubMed ID: 15205180
[TBL] [Abstract][Full Text] [Related]
17. The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.
Courey AJ; Horowitz JC; Kim KK; Koh TJ; Novak ML; Subbotina N; Warnock M; Xue B; Cunningham AK; Lin Y; Goldklang MP; Simon RH; Lawrence DA; Sisson TH
Blood; 2011 Aug; 118(8):2313-21. PubMed ID: 21734232
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats: Role of eIF3a and p27.
Li XW; Hu CP; Li YJ; Gao YX; Wang XM; Yang JR
Int Immunopharmacol; 2015 Jul; 27(1):53-64. PubMed ID: 25957199
[TBL] [Abstract][Full Text] [Related]
19. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
20. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]